Skip to content
Get BIO’s view on everything from health care to biofuels and the bioeconomy. The below articles include BIO statements, opinion, and calls to action, as well as articles and op-eds written by BIO leadership.
International partnerships are vital to delivering new biotech solutions for the health of people and the planet—and strong policies, both in the U.S. and […]
BIO Asia-Taiwan 2023 highlights importance of cross-border collaboration Read More »
In a big week for reauthorization of the Pandemic All Hazards and Preparedness Act (PAHPA), versions of the legislation were approved by a House
PAHPA legislation moves forward in Senate and House Read More »
After the Centers for Medicare & Medicaid Services (CMS) released its guidance for the Drug Price Negotiation Program (Negotiation Program) under the Inflation Reduction
BIO: New CMS guidance a ‘missed opportunity’ for future medical innovation, patients Read More »
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) met on June 12-13, 2023, and announced the formation of
ICH announces discussion group on cell and gene therapy harmonization Read More »
On June 13, the House Energy & Commerce Health Subcommittee held a hearing, Legislative Solutions to Bolster Preparedness and Response for All Hazards and
BIO’s Phyllis Arthur testifies on need to reauthorize PAHPA, pass PASTEUR Act Read More »
During the 2023 BIO International Convention, the Biotechnology Innovation Organization (BIO) released its seventh-annual best practices report, “The U.S. Biosciences Industry in the States:
How can states grow their biosciences sectors? Read More »
The Accelerated Approval pathway has helped deliver groundbreaking treatments to patients—including for diseases like HIV. But lately, the pathway has faced increased pressure, threatening
What’s at stake for Accelerated Approval? Read More »
On May 25, 2023, the Biotechnology Innovation Organization (BIO) and dozens of other biotechnology organizations sent a letter to congressional leaders calling for more
The U.S. Codex Office needs more funding – here’s why Read More »
I grew up like any other American girl—with big ’80s hair and listening to way too much Depeche Mode—but I knew my heritage and
Asian American and Pacific Islanders: Common concerns amid a wealth of diversity Read More »
Inventions like AI-developed drugs belong to the human inventor, says the Biotechnology Innovation Organization (BIO) in comments to the U.S. Patent and Trademark Office
Who owns drugs developed with AI? Read More »
